Skip to main content
Springer logoLink to Springer
. 2020 Feb 26;34(2):253. doi: 10.1007/s40259-020-00410-5

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

Vibeke Strand 1,, Joao Gonçalves 2, Timothy P Hickling 3, Heather E Jones 4, Lisa Marshall 4, John D Isaacs 5
PMCID: PMC7113198  PMID: 32103456

Correction to: BioDrugs (2020) 34:27–37 10.1007/s40259-019-00394-x

The article Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents, written by Vibeke Strand, Joao Gonçalves, Timothy P. Hickling, Heather E. Jones, Lisa Marshall and John D. Isaacs, was originally published Online First without Open Access. After publication in volume 34, issue 1, pages 27–37 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The original article has been corrected.


Articles from Biodrugs are provided here courtesy of Springer

RESOURCES